Literature DB >> 24950050

Prevention and treatment of Clostridium perfringens epsilon toxin intoxication in mice with a neutralizing monoclonal antibody (c4D7) produced in Nicotiana benthamiana.

J P Garcia1, J Beingesser1, O Bohorov2, N Bohorova2, C Goodman2, D Kim2, M Pauly2, J Velasco2, K Whaley2, L Zeitlin2, C J Roy3, F A Uzal4.   

Abstract

Epsilon toxin (ETX), produced by Clostridium perfringens types B and D, is among the most lethal toxins known. ETX is a potential bioterrorism threat that was listed as a Category B agent by the U.S. Centers for Disease Control until 2012 and it still remains a toxin of interest for several government agencies. We produced a monoclonal antibody (MAb) against ETX (ETX MAb c4D7) in Nicotiana benthamiana and characterized its preventive and therapeutic efficacy in mice. The ETX preparation used was highly lethal for mice (LD50 = 1.6 μg/kg) and resulted in a mean time from inoculation to death of 18 and 180 min when administered intravenously or intraperitoneally, respectively. High lethal challenge resulted in dramatic increases of a variety of pro-inflammatory cytokines in serum, while lower, but still lethal doses, did not elicit such responses. ETX MAb c4D7 was highly effective prophylactically (ED50 = 0.3 mg/kg; ED100 = 0.8 mg/kg) and also provided protection when delivered 15-30 min post-ETX intoxication. These data suggest that ETX MAb c4D7 may have use as a pre- and post-exposure treatment for ETX intoxication.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Epsilon toxin; Monoclonal antibody; Nicotiana benthamiana; Preventive; Therapeutic

Mesh:

Substances:

Year:  2014        PMID: 24950050      PMCID: PMC4119486          DOI: 10.1016/j.toxicon.2014.06.012

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  18 in total

1.  Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane.

Authors:  S Miyata; O Matsushita; J Minami; S Katayama; S Shimamoto; A Okabe
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

Review 2.  Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems.

Authors:  Gregory P Pogue; Fakhrieh Vojdani; Kenneth E Palmer; Ernie Hiatt; Steve Hume; Jim Phelps; Lori Long; Natasha Bohorova; Do Kim; Michael Pauly; Jesus Velasco; Kevin Whaley; Larry Zeitlin; Stephen J Garger; Earl White; Yun Bai; Hugh Haydon; Barry Bratcher
Journal:  Plant Biotechnol J       Date:  2010-06       Impact factor: 9.803

3.  Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors.

Authors:  Anatoli Giritch; Sylvestre Marillonnet; Carola Engler; Gerben van Eldik; Johan Botterman; Victor Klimyuk; Yuri Gleba
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

4.  Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N- and C-terminal peptides.

Authors:  J Minami; S Katayama; O Matsushita; C Matsushita; A Okabe
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

5.  Lethal and dermonecrotic activities of Clostridium perfringens lota toxin: biological activities induced by cooperation of two nonlinked components.

Authors:  J Sakurai; K Kobayashi
Journal:  Microbiol Immunol       Date:  1995       Impact factor: 1.955

6.  Development of monoclonal antibodies suitable for use in antigen quantification potency tests for clostridial veterinary vaccines.

Authors:  P J Hauer; N E Clough
Journal:  Dev Biol Stand       Date:  1999

7.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure.

Authors:  Richard Strasser; Johannes Stadlmann; Matthias Schähs; Gabriela Stiegler; Heribert Quendler; Lukas Mach; Josef Glössl; Koen Weterings; Martin Pabst; Herta Steinkellner
Journal:  Plant Biotechnol J       Date:  2008-03-13       Impact factor: 9.803

8.  Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release.

Authors:  Etienne Lonchamp; Jean-Luc Dupont; Laetitia Wioland; Raphaël Courjaret; Corinne Mbebi-Liegeois; Emmanuel Jover; Frédéric Doussau; Michel R Popoff; Jean-Louis Bossu; Jean de Barry; Bernard Poulain
Journal:  PLoS One       Date:  2010-09-30       Impact factor: 3.240

9.  Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma.

Authors:  M Bendandi; S Marillonnet; R Kandzia; F Thieme; A Nickstadt; S Herz; R Fröde; S Inogés; A Lòpez-Dìaz de Cerio; E Soria; H Villanueva; G Vancanneyt; A McCormick; D Tusé; J Lenz; J-E Butler-Ransohoff; V Klimyuk; Y Gleba
Journal:  Ann Oncol       Date:  2010-05-21       Impact factor: 32.976

10.  Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin.

Authors:  Susan L Robertson; Jihong Li; Francisco A Uzal; Bruce A McClane
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

View more
  3 in total

1.  A tripartite cocktail of chimeric monoclonal antibodies passively protects mice against ricin, staphylococcal enterotoxin B and Clostridium perfringens epsilon toxin.

Authors:  Erin K Sully; Kevin Whaley; Natasha Bohorova; Ognian Bohorov; Charles Goodman; Do Kim; Michael Pauly; Jesus Velasco; Frederick W Holtsberg; Eric Stavale; M Javad Aman; Chandra Tangudu; Francisco A Uzal; Nicholas J Mantis; Larry Zeitlin
Journal:  Toxicon       Date:  2014-09-28       Impact factor: 3.033

Review 2.  Recombinant Alpha, Beta, and Epsilon Toxins of Clostridium perfringens: Production Strategies and Applications as Veterinary Vaccines.

Authors:  Marcos Roberto A Ferreira; Gustavo Marçal S G Moreira; Carlos Eduardo P da Cunha; Marcelo Mendonça; Felipe M Salvarani; Ângela N Moreira; Fabricio R Conceição
Journal:  Toxins (Basel)       Date:  2016-11-21       Impact factor: 4.546

3.  Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression.

Authors:  Sugata Roychowdhury; Young J Oh; Hiroyuki Kajiura; Krystal T Hamorsky; Kazuhito Fujiyama; Nobuyuki Matoba
Journal:  Front Plant Sci       Date:  2018-01-30       Impact factor: 5.753

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.